RNA Vaccine; Ivermectin; von Willebrand Factor and COVID-19

65,795 views
•Jul 15, 2020
3K
44
Share
Save
MedCram – Medical Lectures Explained CLEARLY
792K subscribers
The RNA vaccine developed by Moderna now has published data in the New England Journal of Medicine and will be proceeding to the next phase of trials. Dr. Seheult of https://www.medcram.com also discusses compelling hypotheses about the role of von Willebrand Factor in clotting and thrombosis in COVID-19. Finally, Ivermectin has received a significant amount of attention as a potential early treatment of COVID-19. Dr. Seheult discusses a word of caution about in vitro dosages and retrospective observational studies
(This video was recorded July 15, 2020).

THE MEDCRAM WEBSITE: